NSEDisclosure of material issueFundraise31 Jul 2026
Natural Capsules Limited
Disclosure of material issue
Natural Capsules Limited has informed about the approval of the allotment of 9,46,305 equity shares of face value of ₹10 each for cash at par, aggregating to ₹ 94,63,050. This is under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
NSEDisclosure of material issue▼ NegativeDivestiture29 Jul 2026
Natural Capsules Limited
Disclosure of material issue
Natural Capsules Limited has informed about a dilution of 2.18% in its equity stake in subsidiary company Natural Biogenex Private Limited due to non-participation in a Rights Issue.
NSECopy of Newspaper Publication18 Jul 2026
Natural Capsules Limited
Copy of Newspaper Publication
Natural Capsules Limited has informed the Exchange about the completion of dispatch of Notice of 33rd Annual General Meeting and Annual Report for FY 2025-26 through newspaper publication.
NSEShareholders meetingMgmt Change17 Jul 2026
Natural Capsules Limited
Shareholders meeting
Natural Capsules Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2026, to transact various business including appointment of directors, re-appointment of a whole-time director, and approval of related party transactions.
NSERecord Date17 Jul 2026
Natural Capsules Limited
Record Date
Natural Capsules Limited has announced the record date for its 33rd Annual General Meeting as August 5, 2026.
NSECopy of Newspaper PublicationResults16 Jul 2026
Natural Capsules Limited
Copy of Newspaper Publication
Natural Capsules Limited has informed the Exchange about Copy of Newspaper Publication regarding 33rd Annual General Meeting of the Company to be held on August 12, 2026.
NSECertificate under SEBI (Depositories and Participants) Regulations, 201813 Jul 2026
Natural Capsules Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Natural Capsules Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing of new securities on stock exchanges.
NSEGeneral UpdatesFundraise10 Jul 2026
Natural Capsules Limited
General Updates
Natural Capsules Limited has informed the Exchange about General Updates regarding the approval of a Right Issue of 11,16,766 Equity Shares by its Material Unlisted Subsidiary, Natural Biogenex Private Limited.
NSEGeneral UpdatesFundraise10 Jul 2026
Natural Capsules Limited
General Updates
Natural Capsules Limited has informed the Exchange about General Updates, specifically the allotment of 1,11,202 equity shares of Rs. 10 each for cash at par, aggregating to Rs. 11,12,020, as approved by its Material Unlisted Subsidiary, Natural Biogenex Private Limited.
NSECopy of Newspaper PublicationResults26 Jun 2026
Natural Capsules Limited
Copy of Newspaper Publication
Natural Capsules Limited has informed the Exchange about the publication of a newspaper advertisement for the transfer of shares to the Investors Education and Protection Fund (IEPF).
NSETrading Window25 Jun 2026
Natural Capsules Limited
Trading Window
Natural Capsules Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.